Inspection Record

PharMEDium Service, Inc. — FDA 483 Findings

US FDAInspected 2015-07-10Published 2024-01-17 9 findingsTraining and personnelLaboratory and QC controlsAseptic processing and sterility assuranceStability and storageEquipment and facility

Inspectors Stephen D. Brown · Scott T. BallardThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Training and personnel

Clothing of personnel engaged in the manufacturing of drug products is not appropriate for the duties they perform.

2Laboratory and QC controls

Reserve samples for drug products are not retained for one year after the expiration date of the drug product.

3Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established.

4Stability and storage

There is no written testing program designed to assess the stability characteristics of drug products.

5Stability and storage

Drug products do not bear an expiration date determined by appropriate stability data to assure they meet applicable standards of identity, strength, quality and purity at the time of use.

6Equipment and facility

Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

7Laboratory and QC controls

The accuracy and sensitivity of test methods have not been established.

8Laboratory and QC controls

Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the identity and strength of each active ingredient prior to release.

9Laboratory and QC controls

Each batch of drug product required to be free of objectionable microorganisms is not tested through appropriate laboratory testing.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

PharMEDium Service, Inc. company profile — full history US FDA documents, 2024 Go to Findings search